HealthQuartzabout 1 hour ago
Novartis buys UK cancer startup for $1.5B
1 min read
Novartis is acquiring a U.K. cancer drug startup for up to $1.5 billion. The deal includes an upfront payment and additional milestone-based payments. The acquisition expands Novartis's oncology pipeline with the startup's early-stage therapies.
Level
Hype check
Tap to vote and see what everyone thinks.
